Cat. #152534
Anti-ADAM19 [19MOCYT]
Cat. #: 152534
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: ADAM19
Class: Polyclonal
Application: WB
Reactivity: Mouse
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Carl Blobel
Institute: Hospital for Special Surgery
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-ADAM19 [19MOCYT]
- Research fields: Cancer;Cell signaling and signal transduction
- Clone: 19MOCYT
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Molecular weight: ~120 kDa
- Reactivity: Mouse
- Host: Rabbit
- Application: WB
- Description: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.
- Immunogen: GST-fusion protein with the cytoplasmic domain of murine ADAM19
Target Details
- Target: ADAM19
- Molecular weight: ~120 kDa
- Target background: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.
Applications
- Application: WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: Whole serum
- Storage conditions: -20° C
- Shipping conditions: Dry ice
References
- Chesneau et al. 2003. J Biol Chem. 278(25):22331-40. PMID: 12682046.
- Inoue et al. 1998. J Biol Chem. 273(7):4180-7. PMID: 9461614.
- Kawaguchi et al. 2007. J Cell Sci. 120(Pt 6):943-52. PMID: 17344430.
- Zhou et al. 2004. Mol Cell Biol. 24(1):96-104. PMID: 14673146.